← Back to headlines
Guggenheim Adjusts Amgen Inc. Price Target to $351
Guggenheim has adjusted its price target for Amgen Inc. (AMGN) to $351, citing an updated model ahead of the company's earnings report.
23 Apr, 08:41 — 23 Apr, 08:41
Sources
Showing 1 of 1 sources
